T863 |
T863 : Inhibitor of DGAT1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| DGAT1 |
|
|
Inhibitor
up to 100 nM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
Selective against DGAT2: 3.7 %inhibition @ 10 uM compound and ACAT-1 IC50 = 12000 nM
Potency Cellular
In Vitro
DGAT1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1021/jm801507v
In Vivo Validations
Rat
Dose: 1-3 mg/Kg
Route of delivery:
Intravenous, Oral
Plasma half life:
3.0 (IV), 5.6 (PO) h
Systemic clearance:
5.2 mL/min/kg
Bioavailability:
100%
Volume of Distribution at Steady-State:
0.69 L/Kg
DOI Reference: 10.1021/jm801507v
Dog
Dose: 1-3 mg/Kg
Route of delivery:
Intravenous, Oral
Plasma half life:
3.9 (IV), 2.8 (PO) h
Systemic clearance:
12 mL/min/kg
Bioavailability:
>100%
Volume of Distribution at Steady-State:
2.0 L/Kg
DOI Reference: 10.1021/jm801507v
Chemical Information
| Molecular Formula | C22H26N4O3 |
| SMILEs | CC1(C)Oc2ncnc(N)c2N=C1c1ccc([C@H]2CC[C@H](CC(=O)O)CC2)cc1 |
| InChI | InChI=1S/C22H26N4O3/c1-22(2)19(26-18-20(23)24-12-25-21(18)29-22)16-9-7-15(8-10-16)14-5-3-13(4-6-14)11-17(27)28/h7-10,12-14H,3-6,11H2,1-2H3,(H,27,28)(H2,23,24,25)/t13-,14- |
| Molecular weight | 394.20 Da |
| AlogP | 4.099100000000003 |
| HBond acceptors | 7 |
| HBond donors | 3 |
| Atoms | 55 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.